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Objectives: The AFX Endograft with ActiveSealTM technology
features highly conformable STRATA fabric enabling increased conform-
ability within an irregularly shaped aortic neck, with the potential to extend
the zone of sealing beyond the aortic neck. This study comprises the ﬁrst
report of the early clinical experience with the device in a consecutive series
of patients with infrarenal abdominal aortic aneurysms (AAA).
Methods: A retrospective review of the baseline characteristics,
imaging ﬁndings, clinical data, and outcome of consecutive AAA patients
treated with the AFX device (Endologix, Irvine, Calif) at two US centers
was performed by independent monitors. Computed tomographic (CT)
imaging measurements in the overall study population were site-re-
ported. An independent core laboratory assessed aortic neck characteris-
tics and fabric apposition from three-dimensional reformatted CT
datasets in an imaging cohort subset of the study population. The
anatomic neck was deﬁned as the proximal aortic neck where the aortic
diameter remained within 10% of its infrarenal reference. Median follow-
up was 4 (0-14) months overall and 6 (1-14 months) in the imaging
cohort. Values are expressed as mean 6 standard deviation or median
and range.
Results: Among the 108 patients, 103 (95.4%) were treated electively
and 5 (4.6%) were treated urgently for rupture; 80 (74.1%) were male and
28 (25.9%) female with a median age of 70 (56-83) years. An average of
2.3 6 0.7 AFX components was implanted per patient; no proximal neck
bare stents were employed. There were no perioperative deaths in elective
procedures and two deaths in patients with ruptured AAA (40%). Major
adverse events occurred in four elective cases (3.9%) and two ruptured cases
(40%). Over short-term follow-up, two type 1 endoleaks (one 1a, 0.9%; one
1b, 0.9%) and one type 3 endoleak (0.9%) were observed. Type 2 endoleaks
were evident on completion angiography in 18 patients (16.7%), all but one
of which resolved spontaneously by the ﬁrst post procedure CT study.
There were two type 2 endoleaks observed on follow-up CT studies
(1.9%); one of which was not evident at the implant procedure. There
were four aneurysm-related reinterventions; three in elective cases (2.9%)
performed for an iatrogenic iliac arteriovenous ﬁstula, renal stenting for
partial ostial coverage, and a type III endoleak. No patient experienced
endograft migration, limb occlusion, rupture, or open surgical conversion.
In the Imaging Cohort (37 patients), 360-degree fabric-to-wall apposition
continued over a mean length of 25 6 17 mm and extended an average of 5
mm distal to the end of the anatomic neck. Fabric apposition length
exceeded the anatomic neck length in 20 (54%) of the patients in the
Imaging Cohort.
Conclusions: Satisfactory short-term outcome was achieved in an
initial series of patients treated with a new endograft and fabric with the
potential to improve proximal neck sealing. Circumferential fabric apposi-
tion continued beyond the anatomic neck in approximately one-half of
the cases, and there was a low rate of endoleaks and device-related compli-
cations. Deﬁnitive results, however, await the availability of longer term
follow-up data.
Race and Gender Impact Early Outcomes of Lower Extremity Bypass
Ashish K. Jain, Corey A. Kalbaugh, Mark A. Farber, William A. Marston,
Raghuveer Vallabhaneni. University of North Carolina, Chapel Hill, NCTable. Outcomes by race-gender strata
Black females (n ¼ 365) Black males (n ¼
Major complicationsa 0.95 (0.52, 2.22) [P ¼ .86] 1.13 (0.68, 1.88) [
Minor complicationsa 1.26 (0.98, 1.62) [P ¼ .07] 0.97 (0.77, 1.22) [
Deatha 1.67 (0.91, 3.11) [P ¼ .10] 0.87 (0.41, 1.83) [
Graft failurea 3.00 (1.59, 5.63) [P ¼ .001] 1.45 (0.47, 1.73) [
Readmissiona 1.32 (1.00, 1.74) [P ¼ .05] 1.25 (0.96, 1.62) [
Length of stayb 7.7 6 9.0 [P < .0001] 7.1 6 7.3 [P ¼ .00
aPresented as hazard ratio (conﬁdence interval) and [P value] vs referent group.
bPresented as days 6 standard deviation and [P value] vs referent group.Objectives: Race and gender have individually been associated with
affecting outcomes in vascular interventions. We hypothesized that race
and gender stratiﬁcation would help explain variations in outcomes of lower
extremity bypass (LEB) procedures.
Methods: LEB procedures were identiﬁed using current procedural
terminology codes from the 2011 ACS NSQIP database. Persons of races
other than Black or White were excluded because of small sample size.
Preoperative variables such as age, demographics, medical comorbidities,
and laboratory values, were evaluated across race-gender groups using c2,
Student t, and least square means testing. Signiﬁcant predictors were
entered into a multivariate logistic regression model. Six primary outcomes
were evaluated: major complications, minor complications, 30-day
mortality, early graft failure, readmission, and length of stay (LOS). Major
complications included renal failure, pulmonary embolism, stroke, cardiac
arrest, and myocardial infarction. Minor complications included superﬁcial
or wound infections, dehiscence, pneumonia, acute kidney injury, urinary
tract infection, nerve injury, deep vein thrombosis, sepsis, and reoperation.
SAS was used for all statistical computations.
Results: There were a total of 4518 LEB procedures performed on
Black (n ¼ 839, male (BM): females (BF) - 56.6%/43.5%) or White (n ¼
3679, male (WM): female (WF) - 66.4%/33.6%) patients. Black patients
were more likely to be female, diabetic, smokers, and have chronic obstruc-
tive pulmonary disease, critical limb ischemia, or end-stage renal disease
(P < .01). Multivariate analysis revealed no statistically signiﬁcant gender
differences within the white cohort with respect to complications, death,
graft failure, readmission rates, or length of stay (Table). BM had longer
LOS than WM (7.7 6 7.3 vs 5.7 6 6.1; P ¼ .007) following LEB proce-
dures, but there were no other statistically signiﬁcant differences in
outcomes between these groups. BF had a longer LOS than WM (7.76 9.0
vs 5.766.1, P < .0001) as well as a higher chance of being readmitted than
WM (hazard ratio, 1.32; 95% conﬁdence interval, 1.00-1.74; P ¼ .05). BF
also had a much higher risk of early graft failure than WM (hazard ratio,
3.00, 95% conﬁdence interval, 1.59-5.63; P ¼ .001] and trended toward
increased risk of 30-day mortality (Table).
Conclusions: After LEB procedures, race-gender stratiﬁcation may
predict outcomes that may not be predicted by gender or race analysis
alone. To our knowledge, this is the largest population analysis of racial
and gender differences in LEB to date. Further studies using this stratiﬁca-
tion methodology may help provide better insight into optimal therapeutic
strategies and preventative measures for these subgroups of patients. Inves-
tigation into causes of increased LOS in Black patients and increased graft-
failure and readmission rates in Black females may help improve outcomes in
these groups of patients.
Upper Extremity Access for Fenestrated Endovascular Aortic
Aneurysm Repair Is not Associated with Increased Morbidity
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Objectives: Fenestrated endovascular aortic aneurysm repair
(FEVAR) is an alternative to open repair in patients with complex abdom-
inal aortic aneurysms, who are neither ﬁt nor suitable for standard open or
endovascular repair. Chimney and snorkel grafts are other endovascular
alternatives, but require upper extremity access that has been associated to
a 3.2%-9.5% risk of stroke. However, because of the caudal orientation of
the visceral vessels, upper extremity access is also frequently required for
FEVAR. The purpose of this study was to assess the use of upper extremity
access for FEVAR and associated morbidity.474) White females (n ¼ 1235)
White males (referent group)
(n ¼ 2444)
P ¼ .64] 1.20 (0.84, 1.70) [P ¼ .32] 1.0
P ¼ .79] 1.10 (0.94, 1.30) [P ¼ .24] 1.0
P ¼ .71] 1.24 (0.79, 1.92) [P ¼ .35] 1.0
P ¼ .30] 1.22 (0.68, 2.16) [P ¼ .50] 1.0
P ¼ .09] 1.10 (0.91, 1.34) [P ¼ .30] 1.0
7] 5.8 6 5.1 [P ¼ .33] 5.7 6 6.1
